{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:00:51Z","timestamp":1790420451856,"version":"4.1.0"},"reference-count":169,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,13]]},"DOI":"10.5334\/tohm.712","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T07:42:57Z","timestamp":1663054977000},"source":"Crossref","is-referenced-by-count":93,"title":["Tremor in Parkinson\u2019s Disease: From Pathophysiology to Advanced Therapies"],"prefix":"10.5334","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-1673","authenticated-orcid":false,"given":"Ali H.","family":"Abusrair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3451-3061","authenticated-orcid":false,"given":"Walaa","family":"Elsekaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-6571","authenticated-orcid":false,"given":"Saeed","family":"Bohlega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"key":"key20220913074253_B1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and Treatment of Parkinson Disease: A Review","volume":"323","year":"2020","journal-title":"JAMA \u2013 Journal of the American Medical Association"},{"key":"key20220913074253_B2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","article-title":"Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson\u2019s disease","volume":"29","year":"2014","journal-title":"Movement Disorders"},{"key":"key20220913074253_B3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","year":"2017","journal-title":"Nature Reviews Neuroscience"},{"key":"key20220913074253_B4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JPD-150650","article-title":"The clinical evaluation of Parkinson\u2019s tremor","volume":"5","year":"2015","journal-title":"Journal of Parkinson\u2019s Disease"},{"key":"key20220913074253_B5","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"Parkinson\u2019s disease symptoms: The patient\u2019s perspective","volume":"25","year":"2010","journal-title":"Movement Disorders"},{"key":"key20220913074253_B6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/archneurol.2011.147","article-title":"Resting Tremor in Parkinson Disease","volume":"68","year":"2011","journal-title":"Archives of Neurology"},{"key":"key20220913074253_B7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/brain\/awx376","article-title":"Progression of tremor in early stages of Parkinson\u2019s disease: A clinical and neuroimaging study","volume":"141","year":"2018","journal-title":"Brain"},{"key":"key20220913074253_B8","article-title":"Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification","year":"2018","journal-title":"Parkinson\u2019s Disease"},{"key":"key20220913074253_B9","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/mds.23116","article-title":"The identification of Parkinson\u2019s disease subtypes using cluster analysis: A systematic review","volume":"25","year":"2010","journal-title":"Movement Disorders"},{"key":"key20220913074253_B10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/mds.25383","article-title":"How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: Comparison with the unified Parkinson\u2019s disease rating scale","volume":"28","year":"2013","journal-title":"Movement Disorders"},{"issue":"4","key":"key20220913074253_B11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jnnp-2012-303455","article-title":"Parkinson\u2019s disease subtypes: lost in translation?","volume":"84","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20220913074253_B12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s10072-018-3522-z","article-title":"Disease progression in Parkinson subtypes: the PPMI dataset","volume":"39","year":"2018","journal-title":"Neurological Sciences"},{"key":"key20220913074253_B13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mds.21736","article-title":"Paradoxical aspects of parkinsonian tremor","volume":"23","year":"2008","journal-title":"Movement Disorders"},{"key":"key20220913074253_B14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: A review","volume":"311","year":"2014","journal-title":"JAMA \u2013 Journal of the American Medical Association"},{"key":"key20220913074253_B15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: Etiopathogenesis and treatment","volume":"91","year":"2020","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"key20220913074253_B16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/WNL.0b013e3181ae7af1","article-title":"Course in parkinson disease subtypes: A 39-year clinicopathologic study","volume":"73","year":"2009","journal-title":"Neurology"},{"key":"key20220913074253_B17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","article-title":"Parkinson disease subtypes","volume":"71","year":"2014","journal-title":"JAMA Neurology"},{"key":"key20220913074253_B18","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1353-8020(11)70027-X","article-title":"Parkinson\u2019s disease tremor: Pathophysiology","volume":"18","year":"2012","journal-title":"Parkinsonism and Related Disorders"},{"issue":"4","key":"key20220913074253_B19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/WCO.0000000000000829","article-title":"Tremor pathophysiology: lessons from neuroimaging","volume":"33","year":"2020","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 1","key":"key20220913074253_B20","first-page":"S118","article-title":"Tremor: pathophysiology","volume":"20","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"key20220913074253_B21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0037-1601558","article-title":"Pathophysiology and Management of Parkinsonian Tremor","volume":"37","year":"2017","journal-title":"Seminars in Neurology"},{"key":"key20220913074253_B22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mds.27224","article-title":"The cerebral basis of Parkinsonian tremor: A network perspective","volume":"33","year":"2018","journal-title":"Movement Disorders"},{"key":"key20220913074253_B23","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/brain\/aws023","article-title":"Cerebral causes and consequences of parkinsonian resting tremor: A tale of two circuits?","volume":"135","year":"2012","journal-title":"Brain"},{"key":"key20220913074253_B24","doi-asserted-by":"crossref","first-page":"120196","DOI":"10.1016\/j.jns.2022.120196","article-title":"The pathophysiology of Parkinson\u2019s disease tremor","volume":"435","year":"2022","journal-title":"Journal of the Neurological Sciences"},{"key":"key20220913074253_B25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/brain\/awg022","article-title":"The cerebral oscillatory network of parkinsonian resting tremor","volume":"126","year":"2003","journal-title":"Brain"},{"key":"key20220913074253_B26","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1523\/JNEUROSCI.3634-15.2016","article-title":"The cerebral network of parkinson\u2019s tremor: An effective connectivity fMRI study","volume":"36","year":"2016","journal-title":"Journal of Neuroscience"},{"key":"key20220913074253_B27","first-page":"721","article-title":"Dopamine controls Parkinson\u2019s tremor by inhibiting the cerebellar thalamus","volume":"140","year":"2017","journal-title":"Brain"},{"key":"key20220913074253_B28","first-page":"10","article-title":"Deep brain stimulation for tremor: Update on long-term outcomes, target considerations and future directions","year":"2021","journal-title":"Journal of Clinical Medicine"},{"key":"key20220913074253_B29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2015.10.009","article-title":"A brain network model explaining tremor in Parkinson\u2019s disease","volume":"85","year":"2016","journal-title":"Neurobiology of Disease"},{"key":"key20220913074253_B30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.22361","article-title":"Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor","volume":"69","year":"2011","journal-title":"Annals of Neurology"},{"key":"key20220913074253_B31","first-page":"147","article-title":"Primary motor cortex in Parkinson\u2019s disease: Functional changes and opportunities for neurostimulation","year":"2021","journal-title":"Neurobiology of Disease"},{"key":"key20220913074253_B32","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mds.102","article-title":"Imaging of Motor Cortex Physiology in Parkinson\u2019s Disease","volume":"33","year":"2018","journal-title":"Movement Disorders"},{"key":"key20220913074253_B33","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.22221","article-title":"Involvement of the cerebellothalamocortical pathway in Parkinson disease","volume":"68","year":"2010","journal-title":"Annals of Neurology"},{"key":"key20220913074253_B34","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.clinph.2015.02.010","article-title":"Resetting tremor by single and paired transcranial magnetic stimulation in Parkinson\u2019s disease and essential tremor","volume":"126","year":"2015","journal-title":"Clinical Neurophysiology"},{"key":"key20220913074253_B35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.23795","article-title":"Neuropathology of sporadic Parkinson\u2019s disease: Evaluation and changes of concepts","volume":"27","year":"2012","journal-title":"Movement Disorders"},{"key":"key20220913074253_B36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2018.02.039","article-title":"Pallidal dopaminergic denervation and rest tremor in early Parkinson\u2019s disease: PPMI cohort analysis","volume":"51","year":"2018","journal-title":"Parkinsonism and Related Disorders"},{"issue":"6","key":"key20220913074253_B37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease","volume":"50","year":"1991","journal-title":"J Neuropathol Exp Neurol"},{"key":"key20220913074253_B38","first-page":"7","article-title":"Neuropathological diagnostic considerations in hyperkinetic movement disorders","volume":"4","year":"2013","journal-title":"Front Neurol"},{"key":"key20220913074253_B39","first-page":"11","article-title":"Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease","year":"2011","journal-title":"BMC Neurology"},{"key":"key20220913074253_B40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/cns.12670","article-title":"Cognitive Stress Reduces the Effect of Levodopa on Parkinson\u2019s Resting Tremor","volume":"23","year":"2017","journal-title":"CNS Neuroscience and Therapeutics"},{"key":"key20220913074253_B41","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease","volume":"138","year":"2015","journal-title":"Brain"},{"key":"key20220913074253_B42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00702-007-0015-2","article-title":"Loss of thalamic serotonin transporters in early drug-na\u00efve Parkinson\u2019s disease patients is associated with tremor: An [123I] \u03b2-CIT SPECT study","volume":"115","year":"2008","journal-title":"Journal of Neural Transmission"},{"key":"key20220913074253_B43","first-page":"2","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease","year":"2016","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"key20220913074253_B44","first-page":"1","article-title":"Tremor Syndromes: An Updated Review","volume":"12","year":"2021","journal-title":"Frontiers in Neurology"},{"key":"key20220913074253_B45","first-page":"1","article-title":"Tremor: Clinical phenomenology and assessment techniques","volume":"2","year":"2012","journal-title":"Tremor and Other Hyperkinetic Movements"},{"key":"key20220913074253_B46","doi-asserted-by":"crossref","first-page":"e1095","DOI":"10.1212\/WNL.0000000000005215","article-title":"The nature of postural tremor in Parkinson disease","volume":"90","year":"2018","journal-title":"Neurology"},{"key":"key20220913074253_B47","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S1474-4422(20)30036-3","article-title":"Initiation of pharmacological therapy in Parkinson\u2019s disease: when, why, and how","volume":"19","year":"2020","journal-title":"The Lancet Neurology"},{"key":"key20220913074253_B48","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","year":"2020","journal-title":"European Journal of Neurology"},{"key":"key20220913074253_B49","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: A review","volume":"311","year":"2014","journal-title":"JAMA \u2013 Journal of the American Medical Association"},{"key":"key20220913074253_B50","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1212\/WNL.0000000000012868","article-title":"Dopaminergic therapy for motor symptoms in early Parkinson disease practice Guideline summary","volume":"97","year":"2021","journal-title":"Neurology"},{"issue":"Suppl 3","key":"key20220913074253_B51","first-page":"S509","article-title":"Levodopa-related motor complications\u2014phenomenology","volume":"23","year":"2008","journal-title":"Mov Disord"},{"key":"key20220913074253_B52","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/mds.26712","article-title":"Unmasking levodopa resistance in Parkinson\u2019s disease","volume":"31","year":"2016","journal-title":"Movement Disorders"},{"issue":"Pt 6","key":"key20220913074253_B53","first-page":"1701","article-title":"Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson\u2019s disease. A follow-up study of untreated patients","volume":"115","year":"1992","journal-title":"Brain"},{"issue":"5","key":"key20220913074253_B54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.7326\/0003-4819-75-5-703","article-title":"Treatment of parkinsonism with levodopa. Follow-up after 2 years of treatment","volume":"75","year":"1971","journal-title":"Ann Intern Med"},{"key":"key20220913074253_B55","first-page":"9","article-title":"Impact of tremor on patients with early stage parkinson\u2019s disease","year":"2018","journal-title":"Frontiers in Neurology"},{"key":"key20220913074253_B56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.parkreldis.2016.11.015","article-title":"The patient\u2019s perspective: The effect of levodopa on Parkinson symptoms","volume":"35","year":"2017","journal-title":"Parkinsonism and Related Disorders"},{"issue":"2","key":"key20220913074253_B57","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archneur.1986.00520020020009","article-title":"Pharmacologic treatment of parkinsonian tremor","volume":"43","year":"1986","journal-title":"Arch Neurol"},{"issue":"11","key":"key20220913074253_B58","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.parkreldis.2014.09.007","article-title":"Dopamine-responsive pattern in tremor patients","volume":"20","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"key20220913074253_B59","doi-asserted-by":"crossref","first-page":"e1461","DOI":"10.1212\/WNL.0000000000010316","article-title":"Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease","volume":"95","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"key20220913074253_B60","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41531-022-00321-y","article-title":"Mechanisms of peripheral levodopa resistance in Parkinson\u2019s disease","volume":"8","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"key20220913074253_B61","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JPD-191633","article-title":"Long Term Response to Levodopa in Parkinson\u2019s Disease","volume":"9","year":"2019","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"key20220913074253_B62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00002826-199306000-00008","article-title":"Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis","volume":"16","year":"1993","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"key20220913074253_B63","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jnnp.72.6.713","article-title":"Pramipexole in patients with Parkinson\u2019s disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study","volume":"72","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4 Suppl 1","key":"key20220913074253_B64","first-page":"S57","article-title":"Tremor and dopamine agonists","volume":"58","year":"2002","journal-title":"Neurology"},{"key":"key20220913074253_B65","doi-asserted-by":"crossref","first-page":"120194","DOI":"10.1016\/j.jns.2022.120194","article-title":"Medications used to treat tremors","volume":"435","year":"2022","journal-title":"J Neurol Sci"},{"issue":"2","key":"key20220913074253_B66","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.10320","article-title":"Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson\u2019s disease","volume":"18","year":"2003","journal-title":"Mov Disord"},{"key":"key20220913074253_B67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.parkreldis.2019.09.006","article-title":"Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson\u2019s disease","volume":"67","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"key20220913074253_B68","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0753-3322(96)82620-5","article-title":"Apomorphine in patients with Parkinson\u2019s disease","volume":"49","year":"1995","journal-title":"Biomed Pharmacother"},{"key":"key20220913074253_B69","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40263-019-00661-z","article-title":"Apomorphine for Parkinson\u2019s Disease: Efficacy and Safety of Current and New Formulations","volume":"33","year":"2019","journal-title":"CNS Drugs"},{"key":"key20220913074253_B70","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/jnnp.53.11.1004","article-title":"Comparison of motor response to apomorphine and levodopa in Parkinson\u2019s disease","volume":"53","year":"1990","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"key20220913074253_B71","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","year":"2018","journal-title":"Neurology"},{"issue":"7","key":"key20220913074253_B72","first-page":"1044","article-title":"Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial [published correction appears in Arch Neurol.2005 Mar; 62(3): 430]","volume":"61","year":"2004","journal-title":"Arch Neurol"},{"issue":"20","key":"key20220913074253_B73","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"key20220913074253_B74","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s13311-020-00894-7","article-title":"Therapy of Parkinson\u2019s Disease Subtypes","volume":"17","year":"2020","journal-title":"Neurotherapeutics"},{"key":"key20220913074253_B75","first-page":"2010","article-title":"Anticholinergics for symptomatic management of Parkinson\u2019s disease","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"key20220913074253_B76","doi-asserted-by":"crossref","first-page":"106480","DOI":"10.1016\/j.clineuro.2021.106480","article-title":"Impact of anticholinergic drugs withdrawal on motor function in patients with Parkinson\u2019s disease","volume":"202","year":"2021","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"4","key":"key20220913074253_B77","first-page":"CD002258","article-title":"Bromocriptine versus levodopa in early Parkinson\u2019s disease","volume":"2007","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key20220913074253_B78","first-page":"1","article-title":"Effects of combined MAO-B inhibitors and levodopa vs monotherapy in Parkinson\u2019s disease","volume":"6","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"key":"key20220913074253_B79","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/00207454.2013.812085","article-title":"Rasagiline treatment effects on parkinsonian tremor","volume":"123","year":"2013","journal-title":"International Journal of Neuroscience"},{"issue":"12","key":"key20220913074253_B80","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1468-1331.2011.03512.x","article-title":"Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson\u2019s disease","volume":"18","year":"2011","journal-title":"Eur J Neurol"},{"issue":"10","key":"key20220913074253_B81","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199903113401003","article-title":"Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson\u2019s disease","volume":"340","author":"Parkinson Study Group","year":"1999","journal-title":"N Engl J Med"},{"key":"key20220913074253_B82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mdc3.12266","article-title":"Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action","volume":"3","year":"2016","journal-title":"Movement Disorders Clinical Practice"},{"key":"key20220913074253_B83","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/mds.870130302","article-title":"Clozapine use in Parkinson\u2019s disease: A retrospective analysis of a large multicentered clinical experience","volume":"13","year":"1998","journal-title":"Movement Disorders"},{"issue":"1","key":"key20220913074253_B84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/WNF.0b013e3181c47168","article-title":"Current use of clozapine in Parkinson disease and related disorders","volume":"33","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"key20220913074253_B85","first-page":"2010","article-title":"Beta-blocker therapy for tremor in Parkinson\u2019s disease","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"key20220913074253_B86","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s40265-013-0105-4","article-title":"Non-dopaminergic treatments for motor control in Parkinson\u2019s disease","volume":"73","year":"2013","journal-title":"Drugs"},{"issue":"4","key":"key20220913074253_B87","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00002512-200016040-00003","article-title":"Tremor-predominant Parkinson\u2019s disease. Approaches to treatment","volume":"16","year":"2000","journal-title":"Drugs Aging"},{"key":"key20220913074253_B88","doi-asserted-by":"crossref","first-page":"117277","DOI":"10.1016\/j.jns.2020.117277","article-title":"Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study","volume":"421","year":"2021","journal-title":"Journal of the Neurological Sciences"},{"key":"key20220913074253_B89","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: Biology, pharmacology, and toxicology","volume":"69","year":"2017","journal-title":"Pharmacological Reviews"},{"key":"key20220913074253_B90","first-page":"10.7916\/tohm.v0.640","article-title":"Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor","volume":"9","year":"2019","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"key":"key20220913074253_B91","first-page":"13","article-title":"Botulinum Toxin in Movement Disorders: An Update","year":"2021","journal-title":"Toxins (Basel)"},{"key":"key20220913074253_B92","first-page":"1","article-title":"Botulinum toxin for the treatment of hand tremor","volume":"10","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"6","key":"key20220913074253_B93","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mds.870090604","article-title":"Botulinum toxin A injections for the treatment of hand tremors","volume":"9","year":"1994","journal-title":"Mov Disord"},{"key":"key20220913074253_B94","doi-asserted-by":"crossref","first-page":"120203","DOI":"10.1016\/j.jns.2022.120203","article-title":"Botulinum toxin for the treatment of tremor","volume":"435","year":"2022","journal-title":"Journal of the Neurological Sciences"},{"key":"key20220913074253_B95","first-page":"1","article-title":"Novel botulinum toxin injection protocols for parkinson tremor and essential tremor \u2013 the yale technique and sensor-based kinematics procedure for safe and effective treatment","volume":"10","year":"2020","journal-title":"Tremor and Other Hyperkinetic Movements"},{"key":"key20220913074253_B96","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1212\/WNL.56.11.1523","article-title":"A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor","volume":"56","year":"2001","journal-title":"Neurology"},{"key":"key20220913074253_B97","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.mayocp.2017.06.010","article-title":"Botulinum Toxin in Parkinson Disease Tremor: A Randomized, Double-Blind, Placebo-Controlled Study With a Customized Injection Approach","volume":"92","year":"2017","journal-title":"Mayo Clinic Proceedings"},{"key":"key20220913074253_B98","first-page":"1","article-title":"Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections","volume":"12","year":"2017","journal-title":"PLoS ONE"},{"key":"key20220913074253_B99","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJMp1408779","article-title":"Deep-brain stimulation \u2013 Entering the era of human neural-network modulation","volume":"371","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"key20220913074253_B100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/jnnp.2005.081232","article-title":"Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery\u2014experiences from a single centre","volume":"77","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"key20220913074253_B101","first-page":"646","article-title":"Tiefe Hirnstimulation bei idiopathischem Parkinson-Syndrom. Empfehlungen der Deutschen Arbeitsgemeinschaft Tiefe Hirnstimulation [Deep brain stimulation for Parkinson\u2019s disease. Consensus recommendations of the German Deep Brain Stimulation Association]","volume":"80","year":"2009","journal-title":"Nervenarzt"},{"issue":"3","key":"key20220913074253_B102","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s13311-014-0274-1","article-title":"Deep brain stimulation for movement disorders","volume":"11","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"2","key":"key20220913074253_B103","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-2007-971175","article-title":"Deep brain stimulation in movement disorders","volume":"27","year":"2007","journal-title":"Semin Neurol"},{"issue":"1 Movement Disorders","key":"key20220913074253_B104","first-page":"110","article-title":"Deep brain stimulation in movement disorders","volume":"16","year":"2010","journal-title":"Continuum (Minneap Minn)"},{"key":"key20220913074253_B105","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C","article-title":"Core Assessment Program for Surgical Interventional Therapies in Parkinson\u2019s disease (CAPSIT-PD)","volume":"14","year":"1999","journal-title":"Movement Disorders"},{"issue":"4","key":"key20220913074253_B106","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1017\/cjn.2016.35","article-title":"Eligibility Criteria for Deep Brain Stimulation in Parkinson\u2019s Disease, Tremor, and Dystonia","volume":"43","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"key20220913074253_B107","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s00415-020-09810-7","article-title":"Levodopa challenge test: indications, protocol, and guide","volume":"268","year":"2021","journal-title":"Journal of Neurology"},{"issue":"8811","key":"key20220913074253_B108","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0140-6736(92)90457-E","article-title":"Dopamine, tremor, and Parkinson\u2019s disease","volume":"340","year":"1992","journal-title":"Lancet"},{"key":"key20220913074253_B109","article-title":"Levodopa Challenge Test Predicts STN-DBS Outcomes in Various Parkinson\u2019s Disease Motor Subtypes: A More Accurate Judgment","year":"2021","journal-title":"Neural Plasticity"},{"key":"key20220913074253_B110","first-page":"1","article-title":"Can Levodopa Challenge Testing Predict the Effect of Deep Brain Stimulation? One-Year Outcomes in a Chinese Cohort","volume":"13","year":"2021","journal-title":"Frontiers in Aging Neuroscience"},{"key":"key20220913074253_B111","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.brs.2017.12.014","article-title":"Predictors of deep brain stimulation outcome in tremor patients","volume":"11","year":"2018","journal-title":"Brain Stimulation"},{"issue":"5","key":"key20220913074253_B112","article-title":"Deep brain stimulation: a mechanistic and clinical update","volume":"35","year":"2013","journal-title":"Neurosurg Focus"},{"issue":"8","key":"key20220913074253_B113","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5124\/jkma.2013.56.8.695","article-title":"Deep brain stimulation: mechanism, surgical procedure, and clinical applications","volume":"56","year":"2013","journal-title":"J Korean Med Assoc"},{"issue":"9","key":"key20220913074253_B114","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nrneurol.2017.105","article-title":"Insights into the mechanisms of deep brain stimulation","volume":"13","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"key20220913074253_B115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1152\/jn.00281.2015","article-title":"Mechanisms of deep brain stimulation","volume":"115","year":"2016","journal-title":"Journal of Neurophysiology"},{"key":"key20220913074253_B116","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/1073858415581986","article-title":"Mechanism of Deep Brain Stimulation: Inhibition, Excitation, or Disruption?","volume":"22","year":"2016","journal-title":"Neuroscientist"},{"key":"key20220913074253_B117","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.neuroimage.2010.09.028","article-title":"Parkinson\u2019s disease tremor-related metabolic network: Characterization, progression, and treatment effects","volume":"54","year":"2011","journal-title":"Neuroimage"},{"key":"key20220913074253_B118","first-page":"7","article-title":"Neuroimaging evaluation of deep brain stimulation in the treatment of representative neurodegenerative and neuropsychiatric disorders","year":"2021","journal-title":"Bioelectronic Medicine"},{"key":"key20220913074253_B119","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/jnnp-2015-310972","article-title":"Bilateral adaptive deep brain stimulation is effective in Parkinson\u2019s disease","volume":"87","year":"2016","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"key20220913074253_B120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2008.07.019","article-title":"Are two leads always better than one: An emerging case for unilateral subthalamic deep brain stimulation in Parkinson\u2019s disease","volume":"214","year":"2008","journal-title":"Experimental Neurology"},{"key":"key20220913074253_B121","first-page":"1","article-title":"Comparison of efficacy of deep brain stimulation of different targets in Parkinson\u2019s disease: A network meta-analysis","volume":"10","year":"2019","journal-title":"Frontiers in Aging Neuroscience"},{"key":"key20220913074253_B122","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/1756285609339382","article-title":"Deep brain stimulation in Parkinson-s disease","volume":"2","year":"2009","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"key20220913074253_B123","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/cjn.2016.22","article-title":"Deep Brain Stimulation Target Selection for Parkinson\u2019s Disease","volume":"44","year":"2017","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"key20220913074253_B124","doi-asserted-by":"crossref","first-page":"578615","DOI":"10.3389\/fnhum.2020.578615","article-title":"STN Versus GPi Deep Brain Stimulation for Action and Rest Tremor in Parkinson\u2019s Disease","volume":"14","year":"2020","journal-title":"Front Hum Neurosci"},{"key":"key20220913074253_B125","first-page":"1","article-title":"Effect of deep brain simulation on arm, leg, and chin tremor in Parkinson disease [published online ahead of print, 2018 Dec 7]","year":"2018","journal-title":"J Neurosurg"},{"key":"key20220913074253_B126","first-page":"1","article-title":"Revisiting the L-Dopa Response as a Predictor of Motor Outcomes After Deep Brain Stimulation in Parkinson\u2019s Disease","volume":"15","year":"2021","journal-title":"Frontiers in Human Neuroscience"},{"key":"key20220913074253_B127","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.71.5.682","article-title":"Long term safety and efficacy of unilateral deep brain stimulation of the thalamus for parkinsonian tremor","volume":"71","year":"2001","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"key20220913074253_B128","first-page":"1","article-title":"An update on best practice of deep brain stimulation in Parkinson\u2019s disease","volume":"12","year":"2019","journal-title":"Therapeutic Advances in Neurological Disorders"},{"key":"key20220913074253_B129","first-page":"1364","volume":"136","year":"2022","journal-title":"Tremor on medication"},{"key":"key20220913074253_B130","first-page":"1","article-title":"Long-term outcomes following deep brain stimulation for Parkinson\u2019s disease [published online ahead of print, 2019 Jan 18]","year":"2019","journal-title":"J Neurosurg"},{"key":"key20220913074253_B131","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2176\/nmc.oa.2016-0114","article-title":"Predictive factors for long-term outcome of subthalamic nucleus deep brain stimulation for parkinson\u2019s disease","volume":"57","year":"2017","journal-title":"Neurologia Medico-Chirurgica"},{"key":"key20220913074253_B132","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1212\/WNL.0000000000012246","article-title":"Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease","volume":"97","year":"2021","journal-title":"Neurology"},{"key":"key20220913074253_B133","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41582-019-0145-9","article-title":"Long-term outcomes of deep brain stimulation in Parkinson disease","volume":"15","year":"2019","journal-title":"Nature Reviews Neurology"},{"key":"key20220913074253_B134","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/mds.22735","article-title":"Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson\u2019s disease","volume":"25","year":"2010","journal-title":"Movement Disorders"},{"key":"key20220913074253_B135","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/mds.22496","article-title":"Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson\u2019s disease","volume":"24","year":"2009","journal-title":"Movement Disorders"},{"key":"key20220913074253_B136","first-page":"694","article-title":"Multicentre European study of thalamic stimulation for parkinsonian tremor: A 6 year follow-up","volume":"79","year":"2008","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"key20220913074253_B137","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3171\/jns.2006.104.4.506","article-title":"Long-term evaluation of deep brain stimulation of the thalamus","volume":"104","year":"2006","journal-title":"Journal of Neurosurgery"},{"key":"key20220913074253_B138","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.mric.2015.05.008","article-title":"Evolution of Movement Disorders Surgery Leading to Contemporary Focused Ultrasound Therapy for Tremor","volume":"23","year":"2015","journal-title":"Magnetic Resonance Imaging Clinics of North America"},{"key":"key20220913074253_B139","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11910-019-0975-2","article-title":"Focused Ultrasound and Other Lesioning Therapies in Movement Disorders","volume":"19","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"key20220913074253_B140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1227\/NEU.0b013e3182350893","article-title":"Gamma knife thalamotomy for Parkinson disease and essential tremor: a prospective multicenter study","volume":"70","year":"2012","journal-title":"Neurosurgery"},{"key":"key20220913074253_B141","first-page":"584","article-title":"Gamma knife thalamotomy for disabling tremor: A blinded evaluation","volume":"67","year":"2010","journal-title":"Archives of Neurology"},{"key":"key20220913074253_B142","first-page":"1360","article-title":"European Academy of Neurology\/Movement Disorder Society- European Section Guideline on the Treatment of Parkinson\u2019s Disease: I","volume":"37","year":"2022","journal-title":"Invasive Therapies"},{"key":"key20220913074253_B143","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s13311-017-0515-1","article-title":"Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease","volume":"14","year":"2017","journal-title":"Neurotherapeutics"},{"key":"key20220913074253_B144","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10072-020-05020-1","article-title":"Magnetic resonance-guided focused ultrasound for Parkinson\u2019s disease since ExAblate, 2016\u20132019: a systematic review","volume":"42","year":"2021","journal-title":"Neurol Sci"},{"key":"key20220913074253_B145","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1056\/NEJMoa2016311","article-title":"Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson\u2019s Disease","volume":"383","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"key20220913074253_B146","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/neuros\/nyz417","article-title":"Predictors of Outcomes After Focused Ultrasound Thalamotomy","volume":"87","year":"2020","journal-title":"Neurosurgery"},{"key":"key20220913074253_B147","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/jamaneurol.2017.3098","article-title":"Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial","volume":"74","year":"2017","journal-title":"JAMA Neurol"},{"key":"key20220913074253_B148","doi-asserted-by":"crossref","first-page":"601153","DOI":"10.3389\/fneur.2021.601153","article-title":"Bilateral MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson\u2019s Disease With 1-Year Follow-Up","volume":"12","year":"2021","journal-title":"Front Neurol"},{"key":"key20220913074253_B149","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/jnnp-2020-325278","article-title":"Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor: a case series study","volume":"92","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20220913074253_B150","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10143-019-01216-y","article-title":"Safety and efficacy of magnetic resonance imaging-guided focused ultrasound neurosurgery for Parkinson\u2019s disease: a systematic review","volume":"44","year":"2021","journal-title":"Neurosurgical Review"},{"key":"key20220913074253_B151","first-page":"170","article-title":"Treatment of functional disorders with gamma knife thalamotomy","volume":"22","year":"2009","journal-title":"Prog Neurol Surg"},{"issue":"Suppl 3","key":"key20220913074253_B152","first-page":"120","article-title":"Evaluation of gamma thalamotomy for parkinsonian and other tremors: survival of neurons adjacent to the thalamic lesion after gamma thalamotomy","volume":"93","year":"2000","journal-title":"J Neurosurg"},{"key":"key20220913074253_B153","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mds.26625","article-title":"Gamma knife radiosurgery in movement disorders: Indications and limitations","volume":"32","year":"2017","journal-title":"Movement Disorders"},{"issue":"Suppl 3","key":"key20220913074253_B154","first-page":"128","article-title":"Gamma knife thalamotomy for treatment of tremor: long-term results","volume":"93","year":"2000","journal-title":"J Neurosurg"},{"key":"key20220913074253_B155","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3340\/jkns.2015.57.3.192","article-title":"Outcome of gamma knife thalamotomy in patients with an intractable tremor","volume":"57","year":"2015","journal-title":"J Korean Neurosurg Soc"},{"key":"key20220913074253_B156","doi-asserted-by":"crossref","first-page":"673848","DOI":"10.3389\/fnhum.2021.673848","article-title":"Radiofrequency Lesioning for Movement and Psychiatric Disorders-Experience of 107 Cases","volume":"15","year":"2021","journal-title":"Frontiers in Human Neuroscience"},{"issue":"3","key":"key20220913074253_B157","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/ons\/opab169","article-title":"Radiofrequency Ablation for Movement Disorders: Risk Factors for Intracerebral Hemorrhage, a Retrospective Analysis","volume":"21","year":"2021","journal-title":"Oper Neurosurg (Hagerstown)"},{"key":"key20220913074253_B158","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2019.10.004","article-title":"Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors","volume":"76","year":"2020","journal-title":"Parkinsonism and Related Disorders"},{"key":"key20220913074253_B159","first-page":"9","article-title":"Levodopa-Carbidopa Intestinal Gel in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis","year":"2018","journal-title":"Frontiers in Neurology"},{"key":"key20220913074253_B160","first-page":"1","article-title":"Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson\u2019s disease","volume":"2","year":"2016","journal-title":"Npj Parkinson\u2019s Disease"},{"key":"key20220913074253_B161","first-page":"1","article-title":"Non-invasive central and peripheral stimulation: New hope for essential tremor?","volume":"9","year":"2015","journal-title":"Frontiers in Neuroscience"},{"key":"key20220913074253_B162","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.nurt.2008.02.002","article-title":"Noninvasive Brain Stimulation for Parkinson\u2019s Disease and Dystonia","volume":"5","year":"2008","journal-title":"Neurotherapeutics"},{"key":"key20220913074253_B163","doi-asserted-by":"crossref","first-page":"108957","DOI":"10.1016\/j.jneumeth.2020.108957","article-title":"Non-invasive brain stimulation for Parkinson\u2019s disease: Clinical evidence, latest concepts and future goals: A systematic review","volume":"347","year":"2021","journal-title":"Journal of Neuroscience Methods"},{"key":"key20220913074253_B164","first-page":"1","article-title":"Peripherical Electrical Stimulation for Parkinsonian Tremor: A Systematic Review","volume":"14","year":"2022","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"1","key":"key20220913074253_B165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12984-021-00811-9","article-title":"Peripheral electrical stimulation to reduce pathological tremor: a review","volume":"18","year":"2021","journal-title":"J Neuroeng Rehabil"},{"key":"key20220913074253_B166","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1745017901814010089","article-title":"Physical Exercise For Parkinson\u2019s Disease: Clinical And Experimental Evidence","volume":"14","year":"2018","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"8","key":"key20220913074253_B167","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1212\/WNL.0000000000013218","article-title":"Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease","volume":"98","year":"2022","journal-title":"Neurology"},{"key":"key20220913074253_B168","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.conengprac.2010.08.009","article-title":"Neural oscillator based control for pathological tremor suppression via functional electrical stimulation","volume":"19","year":"2011","journal-title":"Control Engineering Practice"},{"key":"key20220913074253_B169","doi-asserted-by":"crossref","first-page":"120197","DOI":"10.1016\/j.jns.2022.120197","article-title":"Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technology","volume":"435","year":"2022","journal-title":"Journal of the Neurological Sciences"}],"container-title":["Tremor and Other Hyperkinetic Movements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-tohm-files\/journals\/1\/articles\/712\/submission\/proof\/712-1-5268-1-10-20220913.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:51:23Z","timestamp":1761551483000},"score":1,"resource":{"primary":{"URL":"https:\/\/tremorjournal.org\/articles\/10.5334\/tohm.712\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":169,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,9,13]]}},"alternative-id":["10.5334\/tohm.712"],"URL":"https:\/\/doi.org\/10.5334\/tohm.712","relation":{},"ISSN":["2160-8288"],"issn-type":[{"value":"2160-8288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"29"}}